FDAnews
www.fdanews.com/articles/101663-immunovaccine-scales-up-vaccimax-to-commercial-scale

ImmunoVaccine Scales Up VacciMax to Commercial Scale

November 30, 2007
ImmunoVaccine Technologies announced that it has successfully scaled-up the manufacturing process for its vaccine platform, Vaccimax. This work validates the suitability of the platform for commercial applications in therapeutic cancer and infectious disease indications.
Yahoo! Finance